Instrument number PB 25 of 2009
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.
Dated 3rd March 2009
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 April 2009.
2 Amendment of PB 121 of 2008
Schedule 1 amends PB 121 of 2008.
Schedule 1 Amendments
[1] Schedule 2, after item dealing with Gemcitabine in the form Powder for I.V. infusion 1 g (as hydrochloride)
insert in the columns in the order indicated:
| Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 20 mL | Injection | 4 | 2 | Gemcitabine Ebewe |
| Solution concentrate for I.V. infusion 1000 mg (as hydrochloride) in 100 mL | Injection | 2 | 2 | Gemcitabine Ebewe |